Literature DB >> 26688984

Collaborative Establishment of an Integrated Orthotic and Rehabilitation Pathway.

Dionisio Ortiz, James A Blair, David M Dromsky, Jay Pyo, Johnny G Owens, Joseph R Hsu.   

Abstract

Returning to active military duty and to recreational activities has been difficult for service members sustaining combat-related high-energy lower extremity trauma (HELET). The Return to Run (RTR) clinical pathway was introduced in 2009 with favorable results in returning active duty service members to running, sports participation, active duty, and deployments. The RTR pathway was introduced at a second institution in 2011 to determine if the pathway could be reproduced at a different institution. In this study, a series of patients is presented who underwent limb salvage procedures after sustaining HELET at an outside military treatment facility and subsequently participated in the authors' RTR protocol. They received a novel orthotic device from the San Antonio Military Medical Center and returned to their home institution for rehabilitation. In this cohort, an improvement in functional capability was obtained in nearly all patients. In conclusion, successful translation of the integrated orthotic and rehabilitation initiative to outside institutions is possible.

Entities:  

Mesh:

Year:  2015        PMID: 26688984

Source DB:  PubMed          Journal:  J Surg Orthop Adv        ISSN: 1548-825X


  2 in total

Review 1.  How New Technology Is Improving Physical Therapy.

Authors:  Johnny G Owens; Michelle R Rauzi; Andrew Kittelson; Jeremy Graber; Michael J Bade; Julia Johnson; Dustin Nabhan
Journal:  Curr Rev Musculoskelet Med       Date:  2020-04

2.  Military Service Members with Major Lower Extremity Fractures Return to Running with a Passive-dynamic Ankle-foot Orthosis: Comparison with a Normative Population.

Authors:  Shian Liu Peterson; Trevor D Kingsbury; Tatiana Djafar; Julianne Stewart; Kevin M Kuhn
Journal:  Clin Orthop Relat Res       Date:  2021-11-01       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.